Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials

Journal:
PLOS Medicine
Published:
Affiliations:
28
Authors:
25
Institutions Authors Share
Frederick National Laboratory for Cancer Research (FNLCR), United States of America (USA)
2.000000
0.08
Copenhagen University Hospital (CUH), Denmark
2.000000
0.08
Intermountain Medical Center, United States of America (USA)
2.000000
0.08
Duke University Health System, United States of America (USA)
2.000000
0.08
UCL, United Kingdom (UK)
1.500000
0.06
Velocity Clinical Research, United States of America (USA)
1.000000
0.04
University of San Francisco (USF), United States of America (USA)
1.000000
0.04
Public Health Institute at Denver Health (PHIDH), United States of America (USA)
1.000000
0.04
Baylor College of Medicine (BCM), United States of America (USA)
1.000000
0.04
National and Kapodistrian University of Athens (UOA), Greece
1.000000
0.04
Baylor University Medical Center at Dallas, United States of America (USA)
1.000000
0.04
Stormont Vail Health, United States of America (USA)
1.000000
0.04
University of New South Wales (UNSW Sydney), Australia
1.000000
0.04
Houston Methodist Hospital, United States of America (USA)
1.000000
0.04
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)
1.000000
0.04
MRC/UVRI and LSHTM Uganda Research Unit, Uganda
1.000000
0.04
University of Minnesota (UMN), United States of America (USA)
1.000000
0.04
Ralph H. Johnson VA Medical Center, United States of America (USA)
1.000000
0.04
University of Toronto (U of T), Canada
0.500000
0.02
National Centre for Infectious Diseases (NCID), Singapore
0.500000
0.02
Royal Free Hospital, United Kingdom (UK)
0.500000
0.02
Washington DC VA Medical Center, United States of America (USA)
0.500000
0.02
The George Washington University (GW), United States of America (USA)
0.500000
0.02